{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:48:24Z","timestamp":1744793304348},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.63.12.1061","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T23:10:02Z","timestamp":1519513802000},"page":"1061-1064","source":"Crossref","is-referenced-by-count":2,"title":["The safety and clinical efficacy of recombinant human granulocyte colony stimulating factor injection for colon cancer patients undergoing chemotherapy"],"prefix":"10.1590","volume":"63","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[{"name":"Northern Jiangsu People's Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Pan","sequence":"additional","affiliation":[{"name":"Jilin University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2017,12]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal A","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.6004\/jnccn.2013.0069","article-title":"National Comprehensive Cancer Network. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines","volume":"11","author":"Benson AB","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6004\/jnccn.2013.0022","article-title":"Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines","volume":"11","author":"3rd Benson AB","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano V","year":"2005","journal-title":"Cancer"},{"issue":"21","key":"ref5","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy a systematic review","volume":"25","author":"Kuderer NM","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref6","first-page":"303","article-title":"Factors influencing in-hospital length of stay and mortality in cancer patients suffering from febrile neutropenia","volume":"9","author":"Lal A","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00044011-200727060-00002","article-title":"Economic burden of haematological adverse effects in cancer patients a systematic review","volume":"27","author":"Liou SY","year":"2007","journal-title":"Clin Drug Investig"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/COC.0b013e31820dc075","article-title":"Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy","volume":"35","author":"Weycker D","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1185\/03007995.2010.536527","article-title":"Comparative effectiveness of colony-stimulating factors for febrile neutropenia a retrospective study","volume":"27","author":"Tan H","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/hum.1998.9.6-835","article-title":"Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine","volume":"9","author":"Thomas MC","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff G","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/10430349950017347","article-title":"A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines","volume":"10","author":"Borrello I","year":"1999","journal-title":"Hum Gene Ther"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.7314\/APJCP.2014.15.4.1699","article-title":"Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer","volume":"15","author":"Cui L","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"19","key":"ref14","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors an evidence-based clinical practice guideline","volume":"24","author":"Smith TC","year":"2006","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.6004\/jnccn.2013.0148","article-title":"Myeloid growth factors","volume":"11","author":"Crawford J","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12865-016-0172-x","article-title":"An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model","volume":"17","author":"Ju H","year":"2016","journal-title":"BMC Immunol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/2326-6066.CIR-13-0143","article-title":"TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells","volume":"2","author":"Narusawa M","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1179\/joc.2008.20.2.278","article-title":"Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen","volume":"20","author":"Correale P","year":"2008","journal-title":"J Chemother"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v63n12\/0104-4230-ramb-63-12-1061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T23:03:12Z","timestamp":1520377392000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302017001201061&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":18,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["S0104-42302017001201061"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.63.12.1061","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}